Zobrazeno 1 - 10 of 98 pro vyhledávání: '"Busch, ORC"'
1
A preoperative prognostic model to predict surgical success in patients with perihilar cholangiocarcinoma
Autor: Gaspersz, Marcia, Buttner, Stefan, Roos, E, van Vugt, Jeroen, Coelen, RJS, Vugts, Jaynee, Wiggers, JK, Allen, PJ, Besselink, MG, Busch, ORC, Belt, EJ, D'Angelica, MI, DeMatteo, RP, de Jonge, Jeroen, Kingham, TP, Polak, Wojtek, Willemssen, Francois, Gulik, TM, Jarnagin, WR, IJzermans, J.N.M., Groot Koerkamp, B
Publikováno v: Journal of surgical oncology, 118(3), 469-476. Wiley-Liss Inc.
Journal of Surgical Oncology, 118(3), 469-476. Wiley-Liss Inc.
Background: Patients with resectable perihilar cholangiocarcinoma (PHC) on imaging have a substantial risk of metastatic or locally advanced disease, incomplete (R1) resection, and 90-day mortality. Our aim was to develop a preoperative prognostic mo
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::87915488bfd8224c71f5ed5a703afa2b
https://pure.amc.nl/en/publications/a-preoperative-prognostic-model-to-predict-surgical-success-in-patients-with-perihilar-cholangiocarcinoma(b39d2b21-e231-494c-b08b-4c17b034d878).html
Zobrazit plný text záznamu
2
Akademický článek
Neoadjuvant chemoradiation followed by surgery versus surgery alone for patients with adenocarcinoma or squamous cell carcinoma of the esophagus (CROSS)
Autor: Richel DJ, Tilanus HW, Wijnhoven BPL, van Dekken H, Steyerberg EW, Muller K, van Berge Henegouwen MI, Koppert LB, van Lanschot JJB, van Heijl M, Busch ORC, Bartelsman JF, Koning CCE, Offerhaus GJ, van der Gaast A
Publikováno v: BMC Surgery, Vol 8, Iss 1, p 21 (2008)
Abstract Background A surgical resection is currently the preferred treatment for esophageal cancer if the tumor is considered to be resectable without evidence of distant metastases (cT1-3 N0-1 M0). A high percentage of irradical resections is repor
Externí odkaz: https://doaj.org/article/ae66bf45b59e46b49bb15893d271bdc5
Zobrazit plný text záznamu
3
Do pancreatic cancer and chronic pancreatitis share the same genetic risk factors? A PANcreatic Disease ReseArch (PANDoRA) consortium investigation
Autor: Campa, D, Pastore, M, Capurso, G, Hackert, T, Di Leo, M, Izbicki, JR, Khaw, K-T, Gioffreda, D, Kupcinskas, J, Pasquali, C, Macinga, P, Kaaks, R, Stigliano, S, Peeters, PH, Key, TJ, Talar-Wojnarowska, R, Vodicka, P, Valente, R, Vashist, YK, Salvia, R, Papaconstantinou, I, Shimizu, Y, Valsuani, C, Zambon, CF, Gazouli, M, Valantiene, I, Niesen, W, Mohelnikova-Duchonova, B, Hara, K, Soucek, P, Malecka-Panas, E, Bueno-de-Mesquita, HBA, Johnson, T, Brenner, H, Tavano, F, Fogar, P, Ito, H, Sperti, C, Butterbach, K, Latiano, A, Andriulli, A, Cavestro, GM, Busch, ORC, Dijk, F, Greenhalf, W, Matsuo, K, Lombardo, C, Strobel, O, König, A-K, Cuk, K, Strothmann, H, Katzke, V, Cantore, M, Mambrini, A, Oliverius, M, Pezzilli, R, Landi, S, Canzian, F
Publikováno v: International Journal of Cancer, 142(2), 290. Wiley-Liss Inc.
International journal of cancer. Journal international du cancer, 142(2), 290-296. Wiley-Liss Inc.
Pancreatic ductal adenocarcinoma (PDAC) is a very aggressive tumor with a five-year survival of less than 6%. Chronic pancreatitis (CP), an inflammatory process in of the pancreas, is a strong risk factor for PDAC. Several genetic polymorphisms have
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::dea0f0c783929fdb2c087de2d5cea9bd
https://pubmed.ncbi.nlm.nih.gov/28913878
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje